Ambev - Companhia de Bebidas das Americas | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (32)

Latest Posts

About This Stock More About This Stock
Inhibikase Therapeutics: Targeted Therapies That Can Improve Quality Of Life
Article By: Ari Zoldan
Thursday, June 17, 2021 12:10 PM EDT
If the company gets the approval for IkT-148009, which is the company’s lead small drug candidate, and any progress is seen in other drug candidates, the shareholder value creation will be significantly greater than the projection mentioned above.
In this article: IKT Also: ABV, AZN, BIIB, DNLI
Read
Small Cap Update
Article By: Vivian Lewis
Sunday, May 1, 2016 2:49 AM EDT
Belgian Galapagos and AbbVie will boost their joint venture in developing a triple drug combo to treat cystic fibrosis. The milestones to the Belgian company were upped for phase 1 and 2 goals from $350 mn to $600 mn.
In this article: ABV, VALE, VRX, ACNDF, LMDCF, TEVA, GLD, PSHZF, BNTC, GLPG
Read

Latest Tweets for $ABV

No tweets yet!

PARTNER HEADLINES